Trading seems to be halted so far today;
bourse-de-paris.fr
The Yahoo board posted something about an announcement
in the afternoon. More interestingly, this was posted
a little over a week ago--who knows? Maybe Famoxin wont
be the bust that the shareprice suggests?
Philipp Scherer speaking on Acrp30
by: bioman24us 06/10/02 05:59 pm
Msg: 1709 of 1725
On June 18, during a conference on Lipoprotein Metabolism at Kimball Union Academy in Meriden, NH, Philipp Scherer (Albert Einstein College of Medicine, New York) will be speaking on "Acrp 30/adiponectin: Role in Systemic Insulin Sensitivity, Glucose and Lipid Metabolism".
At the XIVth World Congress of Pharmacology, July 9, in San Francisco, CA, Philipp Scherer will be speaking on
“Acrp30/Adiponectin: Influence on systemic insulin sensitivity, glucose and lipid homeostasis”.
The bounce in the shares corresponds with this talk,
and also with the arrival of the materials for the
annual meeting.
But I'm not holding my breath. I consider my investment
in Genset a complete bust. If the shares recover for
me a portion of what I've lost these past couple years, great.
...Now what to do about this June 26th meeting?
14 resolutions! --anybody have their materials
at hand--Pernet was voted out, but there is still
a final vote (item 4) huh? I don't often slog through
these to vote my shares, and I think there is a bit
lost in this translation I have. |
